9-ALKYL ANTHRACYCLINES - ABSENCE OF CROSS-RESISTANCE TO ADRIAMYCIN IN HUMAN AND MURINE CELL-CULTURES

被引：38

作者：

SCOTT, CA

WESTMACOTT, D

BROADHURST, MJ

THOMAS, GJ

HALL, MJ

机构：

来源：

BRITISH JOURNAL OF CANCER | 1986年 / 53卷 / 05期

关键词：

D O I：

10.1038/bjc.1986.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：595 / 600

页数：6

共 14 条

[1]

BIEDLER JL, 1970, CANCER RES, V30, P1174

[2] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[3] ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].

DANO, K .

BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483

[4]

HILL BT, 1985, CANCER CHEMOTH PHARM, V14, P194

[5] UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA [J].

INABA, M ;

JOHNSON, RK .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) :2123-2130

[6] TUMOR-CELL RESISTANCE TO ANTHRACYCLINES - A REVIEW [J].

KAYE, S ;

MERRY, S .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) :96-103

[7] MODE OF ACTION OF CALCIUM-ANTAGONISTS WHICH ALTER ANTHRACYCLINE RESISTANCE [J].

KESSEL, D ;

WILBERDING, C .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (07) :1157-1160

[8]

MARAL R, 1983, CURRENT DRUGS METHOD, P189

[9]

OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO

[10]

2-X

← 1 2 →